Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    ARTES 20th Year Anniversary – a short overview

    ARTES Biotechnology GmbH News Releases

    Find the latest News from ARTES Biotechnology GmbH

    Page 1 of 3
    ARTES 20th Year Anniversary – a short overview
    ARTES 20th Year Anniversary – a short overview Learn More >
    ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals
    ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals Learn More >
    Cellumed and ARTES Sign Development and License Agreement
    Cellumed and ARTES Sign Development and License Agreement Learn More >
    “Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations
    “Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations Learn More >
    ARTES is convinced: defeating SARS COVID-19 will require different vaccines
    ARTES is convinced: defeating SARS COVID-19 will require different vaccines Learn More >
    Worldwide, researchers work on a coronavirus vaccine
    Worldwide, researchers work on a coronavirus vaccine Learn More >
    ARTES joins global CV-19 combat with VLP vaccine candidates
    ARTES joins global CV-19 combat with VLP vaccine candidates Learn More >
    France renews CIR tax credits for ARTES R&D services
    France renews CIR tax credits for ARTES R&D services Learn More >
    ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris
    ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris Learn More >
    Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute
    Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute Learn More >
    ARTES presenting new development offer at BIOEurope Spring in Vienna
    ARTES presenting new development offer at BIOEurope Spring in Vienna Learn More >
    ARTES adds SplitCore technology to vaccine development portfolio
    ARTES adds SplitCore technology to vaccine development portfolio Learn More >
    Page 1 of 3